University of Kentucky
Lexington, Kentucky, 40506, United States
Location status: Recruiting
Location contact
Carol White, MPH
CONTACT
Jennifer Havens, PhD
CONTACT
Jennifer Havens, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07804121
The project is a pragmatic, quasi-experimental hybrid type II effectiveness-implementation trial of a structural HIV prevention intervention to address police behavior (arrests and referrals) and ultimately improve health among people who use drugs. The study involves a novel implementation strategy that engages behavioral health workers as "local champions" in the delivery of an evidence-based police education program (SHIELD training intervention). In addition to examining implementation outcomes, primary outcomes focus on assessing effectiveness of the intervention among police (specifically in reducing drug-related arrests and promoting referrals to Medications for Opioid Use Disorder (MOUD) treatment. The investigator's overarching effectiveness hypothesis is that after law enforcement organizations receive the SHIELD training intervention, they will be more likely to refer people who use drugs to MOUD treatment and other health and social services, rather than arresting them for low level possession offenses. The study will be conducted across different counties in Appalachian Kentucky.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Lexington, Kentucky, 40506, United States
Location status: Recruiting
Carol White, MPH
CONTACT
Jennifer Havens, PhD
CONTACT
Jennifer Havens, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SHIELD is an evidence-based police education training program that has been demonstrated to change police behavior (arrest and referrals) and improve outcomes among police and people who use drugs in NIH-funded and other research studies. The original intervention delivery relied on academic teams, limiting sustainability and scalability. Our novel "SHIELD 2.0" implementation strategy aims to address these limitations by capacitating the local behavioral health workforce to implement the steps of the SHIELD process, specifically to complete the delivery of the SHIELD intervention to local police officers.
Time frame: From baseline up to 12 months post SHIELD training
Time frame: From baseline up to 12 months post SHIELD training
Time frame: From baseline up to 12 months post SHIELD training
Survey scores range from 0-12, with lower scores indicating a lower level of stress
Time frame: From baseline up to 12 months post SHIELD training
Survey scores range from 0-24, with lower scores indicating a lower level of burnout
Time frame: From baseline up to 12 months post SHIELD training
Survey scores range from 0-6, with lower scores indicating a lower level of job satisfaction
Contact information is provided by the study sponsor or research team.
Skylar M Chapdelaine, BA
CONTACT
Zach R Salazar, MPH
CONTACT
Johns Hopkins Bloomberg School of Public Health
Other
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07199335
Chemically-Induced Disorders, HIV
Boston, Massachusetts, United States
View Trial DetailsNCT07069374
Behavior, Chemically-Induced Disorders
Oakland, California, United States
View Trial DetailsNCT07414459
Behavior, Behavior, Addictive
Chicago, Illinois, United States
View Trial DetailsNCT05934305
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Miami, Florida, United States
View Trial Details